Pancreatic Cancer Research

ResearcherWashington University in St. LouisNo recent work listed

Steven M. Strasberg

Matched on ORCID iD 0000-0003-0777-2698; OpenAlex author ID A5040229780. Sources: ClinicalTrials.gov.

Their work

Papers
9
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
26
Papers, trials and grants by year

2010: 1 trial · 2011: 1 paper · 2012: 2 papers · 2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 2 papers · 2017: 1 paper · 2018: 1 paper

Papers 9

  1. Utility of Endoscopic Ultrasound in Evaluating Local Recurrence After Surgery for Pancreatic Cancer. Co-author DOI 10.1016/j.cgh.2018.02.031↗
  2. Interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: long-term follow-up. Co-author DOI 10.1016/j.hpb.2017.01.012↗
  3. Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancrea… Co-author DOI 10.1016/s1470-2045(16)00078-4↗
  4. Induction Chemotherapy Followed by Concurrent Full-dose Gemcitabine and Intensity-modulated Radiation Therapy for Borderline Resectable and Locally Advanced Pa… Co-author DOI 10.1097/coc.0000000000000003↗
  5. Natural history of preoperative subcentimeter pulmonary nodules in patients with resectable pancreatic adenocarcinoma: a retrospective cohort study. Co-author DOI 10.1097/sla.0000000000000719↗
  6. A Study of Zoledronic Acid as Neo-Adjuvant, Perioperative Therapy in Patients with Resectable Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.4236/jct.2013.43096↗
  7. Microscopic margins and patterns of treatment failure in resected pancreatic adenocarcinoma. Co-author DOI 10.1001/archsurg.2012.1126↗
  8. Left-sided pancreatic cancer: distal pancreatectomy and its variants: radical antegrade modular pancreatosplenectomy and distal pancreatectomy with celiac axis… Co-author DOI 10.1097/ppo.0b013e31827596c5↗
  9. Influence of obesity and other risk factors on survival outcomes in patients undergoing pancreaticoduodenectomy for pancreatic cancer. Co-author DOI 10.1097/mpa.0b013e318215a9b1↗

Trials 1

  1. Registry Study - Whipple at the Splenic Artery Principal investigator NCT01155882↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. William G. Hawkins · 8 shared papers, 2011–2018 · strength 0.38
  2. Ryan C Fields · 6 shared papers, 2012–2018 · strength 0.33
  3. David C. Linehan · 7 shared papers, 2011–2017 · strength 0.31
  4. Andrea Wang‐Gillam · 6 shared papers, 2011–2018 · strength 0.28
  5. Benjamin R. Tan · 2 shared papers, 2016–2017 · strength 0.12
  6. Dominic E. Sanford · 2 shared papers, 2013–2016 · strength 0.07
  7. Roheena Z. Panni · 2 shared papers, 2013–2016 · strength 0.07
  8. David G DeNardo · 2 shared papers, 2013–2016 · strength 0.07
  9. Kerri A. Ohman · 1 shared paper, 2017 · strength 0.07
  10. Marcus Chuan Beng Tan · 1 shared paper, 2017 · strength 0.07
  11. Gabriel D. Lang · 1 shared paper, 2018 · strength 0.07
  12. Vladimir M. Kushnir · 1 shared paper, 2018 · strength 0.07
  13. Steven Alphonse Edmundowicz · 1 shared paper, 2018 · strength 0.07
  14. Dayna S. Early · 1 shared paper, 2018 · strength 0.07
  15. Parag Jitendra Parikh · 1 shared paper, 2016 · strength 0.05
  16. Shahed Nicolas Badiyan · 1 shared paper, 2016 · strength 0.05
  17. Stephanie T. Chang · 1 shared paper, 2015 · strength 0.05
  18. Timothy M. Nywening · 1 shared paper, 2016 · strength 0.04
  19. Kathryn Jane Fowler · 1 shared paper, 2016 · strength 0.04
  20. Adetunji T. Toriola · 1 shared paper, 2016 · strength 0.04
  21. Kian‐Huat Lim · 1 shared paper, 2016 · strength 0.04
  22. Albert Craig Lockhart · 1 shared paper, 2016 · strength 0.04
  23. Monica Dandona Desai · 1 shared paper, 2011 · strength 0.03
  24. Feng Gao · 1 shared paper, 2011 · strength 0.03
  25. Matthew R. Porembka · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.